Abstract Background terminal deletions of the distal portion of the short arm of chromosome 3 cause a rare contiguous gene disorder characterized by growth retardation, developmental delay, mental retardation, dysmorphisms, microcephaly and ptosis. The phenotype of individuals with deletions varies from normal to severe. It was suggested that a 1,5 Mb minimal terminal deletion including the two genes CRBN and CNTN4 is sufficient to cause the syndrome. In addition the CHL1 gene, mapping at 3p26.3 distally to CRBN and CNTN4, was proposed as candidate gene for a non specific mental retardation because of its high level of expression in the brain. Methods and Results we describe two affected siblings in which array-CGH analysis disclosed an ide...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We describe a de novo 3q27.3q29 deletion in a 2.5-year-old female patient with developmental and gro...
The 3p deletion syndrome is a rare disorder caused by deletions of different sizes in the 3p25-pter ...
CHL1 gene maps at 3p26.3 and encodes a cell adhesion molecule of the immunoglobulin superfamily high...
Abstract Background There is a small, but growing number of reports of pediatric patients with termi...
Copyright © 2014 Leah Te Weehi et al. This is an open access article distributed under the Creative ...
Imbalances of 3p telomeric sequences cause 3p- and trisomy 3p syndrome, respectively, showing distin...
Chromosome microarray analysis is a powerful diagnostic tool and is being used as a first-line appro...
We report on a 3-year-old male with intellectual disability (ID), characteristic facial features, po...
We report on a 3-year-old male with intellectual disability (ID), characteristic facial features, po...
3p deletion syndrome is a rare disorder involving developmental delay, dysmorphic physical features,...
Molecular genetic analysis of five cases of 3p-syndrome (del(3)(qter-p25:)) was performed to investi...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We describe a de novo 3q27.3q29 deletion in a 2.5-year-old female patient with developmental and gro...
The 3p deletion syndrome is a rare disorder caused by deletions of different sizes in the 3p25-pter ...
CHL1 gene maps at 3p26.3 and encodes a cell adhesion molecule of the immunoglobulin superfamily high...
Abstract Background There is a small, but growing number of reports of pediatric patients with termi...
Copyright © 2014 Leah Te Weehi et al. This is an open access article distributed under the Creative ...
Imbalances of 3p telomeric sequences cause 3p- and trisomy 3p syndrome, respectively, showing distin...
Chromosome microarray analysis is a powerful diagnostic tool and is being used as a first-line appro...
We report on a 3-year-old male with intellectual disability (ID), characteristic facial features, po...
We report on a 3-year-old male with intellectual disability (ID), characteristic facial features, po...
3p deletion syndrome is a rare disorder involving developmental delay, dysmorphic physical features,...
Molecular genetic analysis of five cases of 3p-syndrome (del(3)(qter-p25:)) was performed to investi...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We report the identification of six patients with 3q29 microdeletion syndrome. The clinical phenotyp...
We describe a de novo 3q27.3q29 deletion in a 2.5-year-old female patient with developmental and gro...